Lifeward Names Mark Grant as New CEO

Lifeward Names Mark Grant as New CEO Industry veteran brings 30 years of commercial leadership experience GlobeNewswire May 19, 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations […]

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease GlobeNewswire May 19, 2025 — First ever clinical data supporting safety and efficacy of Prime Editing in humans — — Initial data from first patient dosed in Phase 1/2 trial

Hyra Holdings Approves $500M Venture Fund and IPO Roadmap to 2030 at 2025 Annual Meeting

Hyra Holdings Approves $500M Venture Fund and IPO Roadmap to 2030 at 2025 Annual Meeting GlobeNewswire May 19, 2025 HANOI, Vietnam, May 19, 2025 (GLOBE NEWSWIRE) — Hyra Holdings, a global technology investment group, today announced the formal approval of the Hyra Combinator Fund, a $500 million venture initiative aimed at accelerating innovation in AI,

Phase II Data in Treatment-Naive Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy

Phase II Data in Treatment-Naive Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy GlobeNewswire May 19, 2025 — Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder. Regulatory approval for the Phase II trial in

Duke Robotics Strengthens Global Growth Strategy with Appointment of Yuval Hogeg as International Business Development Director

Duke Robotics Strengthens Global Growth Strategy with Appointment of Yuval Hogeg as International Business Development Director Former Head of International Cooperation Unit at Israeli Prime Minister's Office to Lead Duke Robotics' Expansion into Key Global Markets GlobeNewswire May 19, 2025 FT. LAUDERDALE, FL, May 19, 2025 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB:DUKR) (“Duke Robotics”

Tyveo Exchange Partners with WAF: Igniting a New Spark in Stock and Crypto Trading

Tyveo Exchange Partners with WAF: Igniting a New Spark in Stock and Crypto Trading Partnership Background: Bridging Traditional Finance and Digital Assets GlobeNewswire May 19, 2025 New York, NY, May 19, 2025 (GLOBE NEWSWIRE) — In the rapidly evolving global financial landscape, the convergence of traditional finance and digital assets is emerging as a defining

Bath & Body Works Appoints Daniel Heaf as Chief Executive Officer

Bath & Body Works Appoints Daniel Heaf as Chief Executive Officer GlobeNewswire May 19, 2025 Heaf Brings Proven Track Record of Driving Growth Across Iconic Global Consumer Brands Through Product, Retail, and Marketing Transformation Company Pre-Announces First Quarter 2025 Net Sales of $1.4 billion and Earnings Per Diluted Share of $0.49, Meeting the High End

Skillful Craftsman Education Announces New Business Initiatives

Skillful Craftsman Education Announces New Business Initiatives GlobeNewswire May 19, 2025 Shenzhen, China, May 19, 2025 (GLOBE NEWSWIRE) — Skillful Craftsman Education Technology Limited (“Skillful Craftsman” or the “Company”) (NASDAQ: EDTK), a company focused on advancing technological innovation in education through the digital transformation of educational institutions, today announced new business initiatives designed to propel

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches GlobeNewswire May 19, 2025 NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq:

Scroll to Top